Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2020-09-04 2020-09-03
Drug Identification Number 02320185 02320185
Brand name TEVA-TELMISARTAN TEVA-TELMISARTAN
Common or Proper name TELMISARTAN 80MG TAB TELMISARTAN 80MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TELMISARTAN TELMISARTAN
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14 2020-07-14
Estimated end date 2020-12-31 2020-12-31
Actual end date 2020-09-03 2020-09-03
Shortage status Resolved Actual shortage
Company comments Allocating to 100% of Teva market from July to Aug 2020 Allocating to 100% of Teva market from July to Aug 2020
Health Canada comments